Dopingautoriteit jaarverslag 2010 / Dopingautoriteit. - Capelle aan de IJssel, 2011

Annual Report 2010
This is the fifth Annual Report from the Anti-Doping Authority of the Netherlands.

In several respects, 2010 was a transitional year. First of all because it became clear during the course of the year that the Doping Authority will not escape government cutbacks.
As a result, in the years to come, we can expect to get smaller rather than grow.

2010 was also a transitional year: the basic principles were drawn up for changes in the national doping policy and they will affect the work of the Doping Authority in 2011, and later, in several respects.

We look back with satisfaction at a fruitful year and we hope that this annual report will provide you, once again, with a clear picture of the work of our organisation.

U.S. Anti-Doping Agency 2010 Annual Report / United States Anti-Doping Agency (USADA). - Colorado Springs : USADA, 2011

World Anti-Doping Agency 2010 annual report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2011

Contents
02 Chairman’s Message
04 Director General’s Message
06 Foundation Board and Executive Committee
07 The code
08 UNESCO
09 Investigations
10 ADAMS
11 Communications
12 Science and Research
13 Medicine
14 Education
15 Anti-Doping Development
16 Independent Observers
16 Testing
17 2010 Finance Overview

Agence Française de Lutte contre le Dopage (AFLD): 2010 Rapport d’activité

SOMMAIRE
ORGANISATION DE L’AGENCE 4
AVANT-PROPOS 6
CHAPITRE 1 L’ÉVOLUTION INSTITUTIONNELLE 8
I. La révision annuelle de la liste des substances et méthodes interdites 9
II. L’ordonnance du 14 avril 2010 9
III. L’activité délibérative et le pouvoir réglementaire de l’Agence 10
A. Avis et consultations 10
B. Délibérations 10
IV. Le réseau des Agences 11

CHAPITRE 2 L’ACTIVITÉ DE CONTRôLE 12
I. Les priorités arrêtées par le PNAC pour l’année 2010 13
II. Les contrôles antidopage sur les humains 13
A. Répartition des prélèvements 13
B. Contrôles réalisés à l’initiative de l’AFLD et des DRJSCS 14
C. Contrôles réalisés pour le compte de tiers (FI, ANADO) 15
D. Les agréments des préleveurs : bilan au 31 décembre 2010 15
III. La localisation 15
A. Composition du groupe cible de l’AFLD 15
B. Les manquements à l’obligation de localisation constatés en 2010 16
IV. Les contrôles antidopage sur les animaux 16
A. Les agréments des vétérinaires 16
B. La formation des vétérinaires 16
C. Les contrôles réalisés en 2010 16

CHAPITRE 3 LES ANALYSES 22
I. Les contrôles antidopage conventionnels 23
A. L’organisation du contrôle antidopage conventionnel 23
B. Bilan des analyses 23
C. Bilan des échantillons urinaires 24
II. Contrôle antidopage : analyses spécialisées sur échantillons urinaires 24
A. Analyses EPO 24
B. Analyses par spectrométrie de masse de rapport isotopique 24
III. Contrôle antidopage : analyses spécialisées sur échantillons sanguins 24
A. Analyses EPO 24
B. Analyses sanguines (hormone de croissance, hémoglobines modifiées et transfusions) 25
C. Profilage sanguin 25
IV. Les délais de transmission des résultats 25
V. Les rapports d’analyse anormaux 25
A. Les anabolisants 25
B. Le cannabis 26
C. Les glucocorticoïdes 26
D. Salbutamol/terbutaline 26
E. Les agents masquants 26
F. Les stimulants 26
G. Les hormones peptidiques 26
VI. Programme de surveillance 26
VII. L’assurance-Qualité 26
A. Accréditation et évaluation COFRAC 26
B. Essais de comparaison interlaboratoires 26

CHAPITRE 4 LA DéLIVRANCE DES AUT ET L’ACTIVITé DISCIPLINAIRE 28
I. La délivrance des AUT et DU 29
A. Les modifications du Standard international intervenues en 2010 29
B. Le traitement des dossiers 29
II. L’activité disciplinaire 30
A. Typologie et fondements des décisions rendues 30
1. Les différents types de saisines 31
2. Les infractions poursuivies 32
B. Les décisions prononcées 34
1. La nature des décisions prises 34
2. Les conséquences de l’intervention d’une décision disciplinaire 39
C. La validation du mandat des membres des organes disciplinaires fédéraux 39
1. Le formalisme de la demande fédérale 39
2. L’examen au fond des demandes de validation 40
D. Les recours contentieux devant le Conseil d’État 41
1. Les conditions de recevabilité des recours 41
2. Les moyens tirés de l’irrégularité alléguée de la procédure 41
3. Les moyens contestant le bien-fondé de la décision 42

CHAPITRE 5 LA RECHERCHE, LE DÉVELOPPEMENT ET LA PRÉVENTION 46
I. L’activité de recherche et développement du Département des analyses 47
A. Recherche et développement Chimie 47
B. Recherche et développement en biologie 48
II. L’activité de recherche scientifique soutenue par l’Agence 49
A. Les projets retenus par l’Agence en 2010 49
B. La promotion de recherches à caractère biomédical 50
C. Le colloque scientifique de l’ALFD : une journée dédiée à la valorisation de l’activité de recherche soutenue et mise en œuvre par l’AFLD 50
III. Les actions de prévention et de sensibilisation 51
A. Base de médicaments dopants 51
B. Opération de sensibilisation à l’occasion des épreuves de masse 51
C. Mise à jour de la mallette pédagogique « Le sport pour la santé » 51

CHAPITRE 6 LES ÉLEMENTS DE GESTION FINANCIÈRE POUR L’EXERCICE 2010 52
I. L’exécution du budget 2010 de l’AFLD 53
A. Des recettes inférieures aux prévisions 53
B. Des dépenses maîtrisées 53
C. Les investissements 53
II. L’indicateur de performance 5.2 – le coût moyen des contrôles et analyses 54
LES ANNEXES 56

Finnish Anti-Doping Agency annual report 2010 / FINADA

Index
Introduction 3
Administration 4
Board 4
Supervisory Board 4
Therapeutic Use Exemption Committee 4
Quality management 4
Office 4
Doping control and testing 5
Doping testing 5
Therapeutic use exemptions 5
Processing test results 5
Education 6
Communications 7
The Clean Win programme 7
International activities 9
The World Anti-Doping Agency (WADA) 9
The European Council 9
The United Nations Educational, Scientific and Cultural Organisation (UNESCO) 10
Association of National Anti-Doping Organisations (ANADO) 10
International Anti-Doping Arrangement (IADA) 10
Nordic co-operation 10
The European Union 10
Research and reports 11
Development projects 11
Finances 11
Important events during and after the financial year 11
Appendices 12

Annual report 2010-2011 / Drug Free Sport New Zealand (DFSNZ). -  Auckland : DFSNZ, 2011

CONTENTS
Report from Chair person – Michael Heron 2
Report from Chief Executive - Graeme Steel 3
Programme Summaries and Highlights 5
Statement of Service Performance 7
Testing History 12
Testing Year Summary by Sport 13
Athlete Survey Results 14
Directory 17

FINANCIAL STATEMENTS
Statement of Responsibility 17
Statement of Comprehensive Income 18
Statement of Changes in Equity 18
Statement of Cash Flows 19
Statement of Financial Position 20
Notes to Financial Statements 21
Auditors Report 32

Annual Report of the Anti-Doping Unit of the Irish Sports Council for 2010 / Irish Sports Council (ISC). - Dublin : ISC, 2011

Contents:

- Staff
- Contact Details
- Introduction
- Foreword
- List of Abbreviations
- Visions of the Programme
- Education
- Testing
- Research
- International
- Administration
- Background to the Irish Sport Anti-Doping Programme
- Anti-Doping Committee
- Irish Sport Anti-Doping Disciplinary Panel
Chapter 1 Testing
- Highlights
- Doping Controls
- National Programme- Urine
- National Programme- Blood Testing
- Biological Profiling
- User Pays Programme
- Registered Testing Pool
- Criteria for Registered Testing Pool (RTP)
- Whereabouts Failures System
- Missed Test
- Unsuccessful Attempts
- Sample Collection Personnel (SCP)
Chapter 2 International
- Highlights
- International Olympic Committee (IOC) award
- Scientific literacy in Doping and Anti-Doping
- Association of National Anti-Doping Organisations (ANADO)
- World Anti-Doping Agency (WADA)
- Council of Europe 2
Chapter 3 Education and Research
- Highlights
- Educational Resources
- Educational material sent out to various stakeholders in 2010
- Medicines Information
- Eirpharm
- Real Winner
- Education Seminars
Chapter 4 Administration
- Highlights
- SIMON – Anti-Doping Management System
- Sample Collection Personnel Contract
- Intelligence and Investigations
- ISO certification
- Therapeutic Use Exemptions (TUEs)
- TUE Committee
- Applications for Therapeutic Use Exemptions
Chapter 5 The Year Ahead
- The Year Ahead
- Testing
- Administration
- Education
- Research
- International
- Intelligence
- Appendices
Appendix 1
- Anti-Doping Rule Violations
- Adverse Analytical Findings Forwarded to International Federations for Action
- Retroactive TUEs
- Appendix 2
- Costs of the Programmes 2010

Facts
The French Federation for Contact Sport and Associated Disciplines (Fédération Française de Sports de Contact et Disciplines Associées, FFSCDA) charges respondent M43 for a violation of the Anti-Doping Rules. During a K1 event on May 8, 2010, a sample was taken for doping test purposes. The analysis showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
Respondent did mention the occasionally use of cannabis 8 days before the match on the Doping Control Form. But he didn't provide an explanation why it had entered his body.

Decision
1. The sanction is a six months period of ineligibility in which respondent can't take part in competition or sport manifestations organized by the FFSCDA.
2. The decision of September 7, 2010, of the disciplinary committee of the FFSCDA will be modified.
3. The period of ineligibility will be reduced with the period already served by the sanction of September 7, 2010.
4. The results obtained at the event on May 8, 2010, will be cancelled. Medals, points and prizes will be withdrawn.
5. The decision starts on the date of notification.
6. The decision will be published and sent to the parties involved.

Facts
The French Federation for Contact Sport and Associated Disciplines (Fédération Française de Sports de Contact et Disciplines Associées, FFSCDA) charges respondent M42 for a violation of the Anti-Doping Rules. During a muaythai event on March 14, 2010, a sample was taken for doping test purposes. The analysis showed the presence of terbutaline. Terbutaline is a prohibited substance according the World Anti Doping Agency (WADA) prohibited list.

History
Respondent didn't provide any information about how the prohibited had entered his body. He did mention that he suffers from allergies on the Doping Control form.

Decision
1. The sanction is a period of ineligibility of nine months in which respondent can't take part in competition or manifestations organized or authorized by the FFSCDA.
2. The decision (six months period of ineligibility) of September 7, 2010, of the disciplinary committee of the FFSCDA will be modified.
3. The period of ineligibility will be reduced by the period already served by the decision of September 7, 2010.
4. All the results obtained at the muaythai event on March 14, 2010, will be cancelled. Medals, points and prizes will be withdrawn.
5. The decision starts on the date of notification.
6. The decision will be published and sent to the parties involved.

The Netherlands Ice Hockey Association (Nederlandse IJshockey Bond, NIJB) has reported an anti doping rule violation against 2 players after their samples tested positive for the prohibited substance methylhexaneamine (dimethylpentylamine) during two separate anti-doping tests.
Players stated they didn’t know they used a supplement containing a prohibited substance because the label of the supplement did not mention it as ingredient.
The committee accepts the statement of the players as mitigating circumstances. Therefore the players had no intention to enhance their performance. The committee concludes that the players didn’t make further inquiries about the ingredients in the supplement and decides, because of exceptional circumstances, for a period of ineligibility until October 1, 2011.
In additon related to prohibited substance contaminations in supplements, the Disciplinary Committee made an appeal about improving information and prevention addressed to:
- Netherlands Ice Hockey Association
- Ice hockey clubs
- Doping Authority
- The Netherlands Security System Nutritional Supplements Elite Sports
- Players